Cough variant asthma (CVA) is treated with the same core medications used for classic asthma, primarily a daily inhaled corticosteroid to reduce airway inflammation. The difference is that CVA produces a persistent dry cough rather than wheezing or shortness of breath, which often delays diagnosis. Once identified, though, treatment typically brings significant relief within a few weeks.
Daily Inhaled Corticosteroids: The Main Treatment
The foundation of CVA treatment is a maintenance inhaler containing a corticosteroid, used every day whether or not you’re coughing at the time. These medications work by calming the inflammation and excess mucus production in your airways that trigger the cough reflex. You won’t feel immediate relief the way you might with a pain reliever. Inhaled corticosteroids need consistent daily use to build up their anti-inflammatory effect, and most people notice meaningful improvement over two to four weeks.
The key word here is “maintenance.” Unlike a rescue inhaler you grab during a flare-up, this is a daily commitment. Skipping doses because your cough has quieted down is one of the most common reasons symptoms return. Your doctor will determine the appropriate strength based on how severe your cough is and how well you respond to initial treatment. If a low dose doesn’t bring your cough under control, the next step is usually increasing to a medium dose or adding a second medication.
Rescue Inhalers for Flare-Ups
In addition to a daily maintenance inhaler, you’ll likely be prescribed a short-acting bronchodilator (a “rescue” inhaler) to use when your cough spikes. These work by relaxing the muscles around your airways within minutes, opening them up and easing the cough. They’re not a substitute for daily treatment. They manage symptoms in the moment but do nothing about the underlying inflammation driving the condition.
Rescue inhalers also play a role in diagnosis. If your chronic cough improves noticeably after using a bronchodilator, that response itself helps confirm that asthma is the cause, not acid reflux, postnasal drip, or another common cough trigger.
Leukotriene Blockers as an Add-On
For people who don’t fully respond to inhaled corticosteroids alone, or who prefer an oral medication, a class of drugs called leukotriene receptor antagonists can help. These pills block chemical signals in your body that promote airway inflammation. In a multicenter study of CVA patients, those taking a leukotriene blocker alone achieved an asthma control rate of about 84% after four weeks. Nearly 79% of participants saw their cough scores drop by more than 25% from baseline. Improvement typically started within the first two weeks and continued through week four, with a noticeable increase in cough-free days and nights.
Combination regimens, pairing a leukotriene blocker with an inhaled corticosteroid, produced similar control rates (around 82 to 84%). This makes leukotriene blockers a useful option either on their own for milder cases or as a complement to inhaler therapy when your cough isn’t fully controlled.
Treatment for Children
Children ages six to eleven with CVA follow a similar stepwise approach, adjusted for age. The preferred starting point is a daily low-dose inhaled corticosteroid paired with a rescue inhaler as needed. A leukotriene blocker is considered a less effective but acceptable alternative at this step, particularly for kids who struggle with inhaler technique.
If symptoms aren’t controlled on a low dose, the next move is either a medium-dose inhaled corticosteroid or a combination of a low-dose corticosteroid with a long-acting bronchodilator. Children whose cough persists despite a medium-dose corticosteroid should be referred to a specialist. Younger children often use a spacer device attached to their inhaler, which makes it easier to get the medication deep into the lungs rather than depositing it in the mouth and throat.
Older Medications That Have Fallen Out of Favor
Theophylline, a medication that was once commonly prescribed for asthma, is no longer recommended in current treatment guidelines. Both the Global Initiative for Asthma (GINA) and the European Respiratory Society/American Thoracic Society guidelines have dropped it from their asthma management algorithms. The reason is straightforward: it doesn’t work reliably, and it carries a relatively high risk of side effects. Systematic reviews found no benefit of adding theophylline to standard bronchodilator treatment in either adults or children. It still occasionally appears in hospitals as a last resort for severe asthma that doesn’t respond to anything else, but for CVA, it has no meaningful role.
Identifying and Avoiding Your Triggers
Medications control the inflammation, but avoiding the things that provoke your airways in the first place reduces how often you need them. Common CVA triggers overlap with those of classic asthma: dust mites, pet dander, mold, pollen, cold air, strong fragrances, cigarette smoke, and respiratory infections. Exercise and stress can also set off coughing episodes.
Practical steps that make a real difference include using allergen-proof covers on pillows and mattresses, running a HEPA filter in your bedroom, keeping indoor humidity below 50% to discourage mold and dust mites, and avoiding exercising outdoors on high-pollen or very cold days. If cold air is a reliable trigger, breathing through a scarf or neck gaiter in winter can warm the air before it hits your airways. These aren’t replacements for medication, but they reduce the burden on your already-sensitive airways and can mean fewer flare-ups over time.
Why Consistent Treatment Matters
CVA carries a real risk of progressing to classic asthma with wheezing, chest tightness, and shortness of breath. Consistent treatment with inhaled corticosteroids is the best-studied way to reduce that risk. The temptation to stop once your cough disappears is strong, especially since the cough is the only obvious symptom. But the airway inflammation that causes CVA doesn’t resolve just because the cough quiets down. Stopping treatment prematurely often leads to the cough returning within weeks or months.
Your treatment plan will likely evolve over time. If your cough stays well-controlled for several months, your doctor may try stepping down to a lower dose. If it worsens seasonally or after respiratory infections, you may temporarily step up. The goal is finding the minimum effective treatment that keeps you cough-free while minimizing medication use over the long term.